Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach

Hepatobiliary Pancreat Dis Int. 2024 Jun;23(3):317-321. doi: 10.1016/j.hbpd.2023.02.010. Epub 2023 Feb 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic / metabolism
  • Cell Line, Tumor
  • Cholangiocarcinoma* / drug therapy
  • Humans
  • NF-E2-Related Factor 2 / metabolism

Substances

  • NF-E2-Related Factor 2